James Ashton

University of Southampton
Country flagUnited Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (13)

Year:

2026

Year:

2026

Background and aims The centenary of Archives of Disease in Childhood ( ADC ) presents an opportunity to reflect on a century of paediatric research and consider how best to leverage this ever-growing repository for future use. While content is indexed via PubMed and medical subject headings terms, this provides a superficial representation of complex journal content, leading to limited accessibility. We discuss the potential utility of large language models (LLMs)—advanced artificial intelligence systems that can understand, summarise and generate human-like language—and demonstrate their feasibility for structuring historical ADC articles, proposing a future pipeline to enhance indexing, retrieval and discoverability. Methods For demonstrative purposes, five articles from ADC December 1999 issue were locally downloaded and processed using a closed deployment of an LLM, Mistral (V.0.3, 7B). A structured prompt was used to extract key metadata. Outputs were manually compared with source texts and scored for accuracy. Hallucinations, fabricated or incorrect outputs, were recorded. Results The LLM achieved a mean accuracy of 86.9%, aligning with previous benchmarks for medical research assistance. No hallucinations were identified. Some repetition and verbosity were noted, likely due to chunk-based processing, but key fields were accurately extracted when explicitly present. Conclusion ADC holds a vast but underutilised body of research. This article shows that lightweight, locally hosted LLMs could structure ADC content without compromising intellectual property. Such methods could enable improved access, support automation of systematic reviews and enhance discoverability through biomedical ontologies, laying the foundation for a searchable, semantically enriched Archive s that bridges historical insight with modern research needs.

Year:

2026

Year:

2025

Endoplasmic reticulum aminopeptidases (ERAP) facilitate antigen presentation. Variation in ERAP1 and ERAP2 genes underwent selection during the Black Death and impact autoimmune disease susceptibility. We assess the burden of functionally impactful variants present in ERAP1 and ERAP2 in 2 cohorts of patients diagnosed with inflammatory bowel disease (IBD; Crohn’s disease (CD) or ulcerative colitis (UC)). We analysed the Southampton Genetics of IBD cohort comprising patients diagnosed with IBD, with exome and clinical data on autoimmune comorbidities (n CD = 661, n UC = 330); and a subset of UK Biobank IBD patients and selected controls (n CD = 891, n UC = 1409, n control = 60,075). Common single variants (minor-allele-frequency > 0.05) underwent Fisher’s exact test with permutations (n = 1000), comparing UC versus CD patients in the Southampton cohort. A gene-burden based test of functionally impactful variants (GenePy) was used to examine rare and common variants in both cohorts. Predicted haplotypes were assessed in each cohort and compared with known haplotypes of ERAP1 and ERAP2 . In the Southampton cohort, variant-level analysis identified 6 common variants that were nominally significant when testing between UC versus CD ( p < 0.05; empirical permuted p-value). Gene-level analysis using Mann–Whitney-U identified an altered burden of functionally impactful variants for ERAP1 in UC versus CD patients ( p = 0.0073), but not for ERAP2 . Patients with an isolated diagnosis of UC ( p = 0.037,θ = 0.457) vs patients with a concurrent diagnosis of UC and any autoimmune diagnoses had an altered burden of functionally impactful variants in ERAP2 . For the UK Biobank cohort, participants diagnosed with UC versus controls had a significantly altered burden of functionally impactful variants in ERAP1 ( p = 0.0004) and ERAP2 ( p = 0.0006). Both variant and gene-level analysis indicate a role for ERAP1 and ERAP2 in predisposing individuals to developing UC or UC with concurrent autoimmune diagnosis.

Year:

2025

Year:

2025

Whole exome sequencing (WES) is a well-established tool for clinical diagnostics, is more cost-effective and faster to analyse than whole genome sequencing and has been implemented to uplift diagnostic rates in human disease. However, challenges remain to achieve comprehensive and uniform coverage of targets, and high sensitivity and specificity. Differences in genomic target regions and exome capture mechanism between kits may lead to differences in overall coverage uniformity and capture efficiency. Here, we analyse the efficiency of a range of off-the-shelf exome sequencing (ES) kits in capturing their reported targets and the consensus coding sequence (CCDS) regions. Our results show Twist Custom Exome, Twist Human Comprehensive Exome, and Roche KAPA HyperExome V1 perform particularly well at capturing their target regions at 10X and 20X coverage and achieve the highest capture efficiency of CCDS regions upon read downsampling. This was the case despite both Twist kits targeting less than 37Mb in the genome. Our analysis highlights the impact of kit target design on capture efficiency in WES, with kit target size and uniformity of coverage impacting the capture efficiency of CCDS regions. This benchmark will help researchers to make an informed decision based on their needs.

Year:

2025

Adolescence represents a key period in the management of inflammatory bowel disease (IBD), encapsulating physical, psychological and social change. Increasing incidence of paediatric-onset IBD has led to a growing adolescent population. This review explores contemporary challenges in adolescent IBD management, including growth and development, psychosocial factors and treatment. Growth failure, once common in paediatric-onset IBD, has decreased; however, sarcopenic obesity is increasingly recognised, impacting long-term outcomes. Anxiety and depression are widely prevalent, with bidirectional relationships between disease activity and mental health contributing to increased disease burden. Poor sleep quality and fatigue further affect quality of life. The expanding therapeutic landscape offers new agents, yet licensing delays for adolescent use remain. Long-term safety concerns, including risks to fertility and cancer development, necessitate careful integration. Non-adherence is a significant barrier to effective treatment. Transitioning to adult care is a critical period requiring structured, patient-centred approaches to optimise disease control. Multidisciplinary teams caring for individuals with IBD must recognise relevant issues such as fertility and sexual health which remain unaddressed. Surgical considerations, including ‘ostomy’ procedures, require sensitive discussions incorporating patient autonomy and psychological support. Body image concerns contribute to anxiety and depression, underscoring the need for perioperative counselling. Social factors, including school absenteeism and employment concerns, highlight the importance of holistic, flexible multidisciplinary management. Healthcare engagement on social media may aid in disseminating reliable IBD information. This review emphasises the need for an integrated, developmentally appropriate, multidisciplinary approach to ensure optimal health and well-being in adolescents with IBD.

Year:

2025

Year:

2025

Structured phenotypic annotations linked to genetic data can drive diagnostic insight and therapeutic discovery in complex diseases. However, poor research access to the rich clinical data trapped in unstructured clinical records remains a significant barrier to phenotype—genotype integration. Here, we present Human Phenotype Ontology (HPO) Mapper, a scalable AI-assisted tool designed to ingest semantically structured clinical findings paired with anatomical region and accurately map them to HPO terms and associated genes. We applied HPO Mapper to two forms of standardised clinical input extracted from inflammatory bowel disease (IBD) patient records. The first data type consisted of paired "clinical findings + anatomical regions" derived from unstructured clinical reports and the second was standardised ICD-10 code-derived phenotypes. HPO Mapper achieved high semantic alignment and mapping accuracy for both data types (F1 = 0.85 ± 0.05 and 0.84 ± 0.03, respectively). Our publicly available tool enables real-time HPO mapping for clinical applications providing a foundation for scalable AI-driven phenotyping across diseases.

Year:

2025

Year:

2025

Year:

2025

Year:

2020

Collaborators (8)

Christopher Kipps

Professor

University of Southampton

UNITED KINGDOM
View details

Nadeem Ahmad Afzal

Associate Professor (Hon)

University of Southampton

UNITED KINGDOM
View details

Peter Robinson

Professor for Medical Computer Science

The Jackson Laboratory for Genomic Medicine

UNITED STATES
View details

Aneurin Young

University of Southampton

UNITED KINGDOM
View details

Mark Johnson

University of Southampton

UNITED KINGDOM
View details

Gabriela Czanner

Senior Lecturer in Statistics and Data Science

University of Southampton

UNITED KINGDOM
View details

Sarah Ennis

Professor of Genomics

University of Southampton

UNITED KINGDOM
View details

Robert Mark Beattie

Consultant Paediatric Gastroenterologist/Honorary Professor of Paediatric Gastroenterology and Nutrition

University Hospital Southampton NHS Foundation Trust

UNITED KINGDOM
View details